Compare EXEL & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | SENEB |
|---|---|---|
| Founded | 1994 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 813.0M |
| IPO Year | 2000 | N/A |
| Metric | EXEL | SENEB |
|---|---|---|
| Price | $44.21 | $109.56 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $45.18 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 495.0 |
| Earning Date | 02-10-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | 47.79 |
| EPS | 2.38 | ★ 8.61 |
| Revenue | ★ $2,288,218,000.00 | $1,606,175,000.00 |
| Revenue This Year | $9.79 | N/A |
| Revenue Next Year | $12.01 | N/A |
| P/E Ratio | $18.53 | ★ $12.60 |
| Revenue Growth | ★ 9.93 | 8.33 |
| 52 Week Low | $31.90 | $71.47 |
| 52 Week High | $49.62 | $124.94 |
| Indicator | EXEL | SENEB |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 49.48 |
| Support Level | $40.83 | $108.68 |
| Resistance Level | $47.24 | $115.00 |
| Average True Range (ATR) | 1.16 | 0.39 |
| MACD | 0.17 | -1.55 |
| Stochastic Oscillator | 51.90 | 5.41 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.